Hanmi's Merger Plan Could Spark Power Struggle In South Korea Pharma Sector

OCI Alliance Good For Future Cash Flow?

An unexpected merger between Korea's Hanmi Pharm Group and chemical group OCI may raise eyebrows in terms of likely synergies, but analysts are viewing the planned transaction positively in terms of future cash flow. However, resistance from some members of Hanmi's founder family may mean a possible leadership struggle at the pharma company.

M&A
Merger Approved Unanimously At Hanmi Science, OCI Holdings Boards • Source: Shutterstock

Hanmi Pharm Group has announced a surprise merger with OCI Group in a deal that would place the leading South Korean pharmaceutical firm, with a portfolio including consumer health products, under the wing of the large compatriot energy and chemical enterprise.

Hanmi expects the move to help secure the investment it needs to grow into a truly global biopharma operation. “Hanmi...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Deals

More from Business